167 related articles for article (PubMed ID: 23614622)
21. Cellular Senescence and Anti-Cancer Therapy.
You J; Dong R; Ying M; He Q; Cao J; Yang B
Curr Drug Targets; 2019; 20(7):705-715. PubMed ID: 30556499
[TBL] [Abstract][Full Text] [Related]
22. Induction of senescence in cancer cells by 5'-Aza-2'-deoxycytidine: Bioinformatics and experimental insights to its targets.
Putri JF; Widodo N; Sakamoto K; Kaul SC; Wadhwa R
Comput Biol Chem; 2017 Oct; 70():49-55. PubMed ID: 28802167
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-224: as a potential target for miR-based therapy of cancer.
Chen W; Fan XM; Mao L; Zhang JY; Li J; Wu JZ; Tang JH
Tumour Biol; 2015 Sep; 36(9):6645-52. PubMed ID: 26254100
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs and cancer; an overview.
Tutar L; Tutar E; Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):430-7. PubMed ID: 24846068
[TBL] [Abstract][Full Text] [Related]
25. miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents.
Qian B; Nag SA; Su Y; Voruganti S; Qin JJ; Zhang R; Cho WC
Curr Cancer Drug Targets; 2013 Jun; 13(5):519-41. PubMed ID: 23597193
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance.
Ghandadi M; Sahebkar A
Curr Pharm Des; 2016; 22(7):933-9. PubMed ID: 26648462
[TBL] [Abstract][Full Text] [Related]
27. DNA damage response regulation by microRNAs as a therapeutic target in cancer.
Majidinia M; Yousefi B
DNA Repair (Amst); 2016 Nov; 47():1-11. PubMed ID: 27697364
[TBL] [Abstract][Full Text] [Related]
28. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
Malaquin N; Martinez A; Rodier F
Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
[TBL] [Abstract][Full Text] [Related]
29. Identifying MicroRNA Pathway Variants as Biomarkers of Patient Selection for Immune Therapy.
Weidhaas JB
Methods Mol Biol; 2020; 2055():203-212. PubMed ID: 31502153
[TBL] [Abstract][Full Text] [Related]
30. Regulatory microRNA networks: complex patterns of target pathways for disease-related and housekeeping microRNAs.
Zafari S; Backes C; Leidinger P; Meese E; Keller A
Genomics Proteomics Bioinformatics; 2015 Jun; 13(3):159-68. PubMed ID: 26169798
[TBL] [Abstract][Full Text] [Related]
31. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells.
Schwarze SR; Fu VX; Desotelle JA; Kenowski ML; Jarrard DF
Neoplasia; 2005 Sep; 7(9):816-23. PubMed ID: 16229804
[TBL] [Abstract][Full Text] [Related]
32. Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review.
Ali SR; Humphreys KJ; McKinnon RA; Michael MZ
Drug Dev Res; 2015 Sep; 76(6):296-317. PubMed ID: 26303212
[TBL] [Abstract][Full Text] [Related]
33. What is and what is not cell senescence.
Sikora E; Bielak-Żmijewska A; Mosieniak G
Postepy Biochem; 2018 Oct; 64(2):110-118. PubMed ID: 30656893
[TBL] [Abstract][Full Text] [Related]
34. Signaling by exosomal microRNAs in cancer.
Falcone G; Felsani A; D'Agnano I
J Exp Clin Cancer Res; 2015 Apr; 34(1):32. PubMed ID: 25886763
[TBL] [Abstract][Full Text] [Related]
35. Deep sequencing of small RNA libraries from human prostate epithelial and stromal cells reveal distinct pattern of microRNAs primarily predicted to target growth factors.
Singh S; Zheng Y; Jagadeeswaran G; Ebron JS; Sikand K; Gupta S; Sunker R; Shukla GC
Cancer Lett; 2016 Feb; 371(2):262-73. PubMed ID: 26655274
[TBL] [Abstract][Full Text] [Related]
36. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.
Qin C; Huang RY; Wang ZX
Tumour Biol; 2015 Mar; 36(3):1403-9. PubMed ID: 25740059
[TBL] [Abstract][Full Text] [Related]
37. Senescence-associated microRNAs target cell cycle regulatory genes in normal human lung fibroblasts.
Markopoulos GS; Roupakia E; Tokamani M; Vartholomatos G; Tzavaras T; Hatziapostolou M; Fackelmayer FO; Sandaltzopoulos R; Polytarchou C; Kolettas E
Exp Gerontol; 2017 Oct; 96():110-122. PubMed ID: 28658612
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA Regulation of Oxidative Stress-Induced Cellular Senescence.
Bu H; Wedel S; Cavinato M; Jansen-Dürr P
Oxid Med Cell Longev; 2017; 2017():2398696. PubMed ID: 28593022
[TBL] [Abstract][Full Text] [Related]
40. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
Humphries B; Yang C
Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
